Pharma Exec Blog
The Business of Pharmaceuticals
Skip to content
  • Archives
  • Now in Video, the Prix Galien Winners
  • “Salami-slicing” orphan drugs
  • European pharma: go easy on your lobbyists!
  • Europe: Go easy on your lobbyists
  • Contact
Home / PharmExec BlogPharmExec Blog / Follow Us on TwitterFollow Us / Podcasts Podcasts / RSSRSS / BookstoreBookstore
  • Magazine
    • Pharmaceutical Executive Magazine
    • Pharm Exec Europe Digest
    • Columnists
    • Product Managers Handbook
    • Consultants Confidential
    • Pharma Meetings
    • Agency Confidential
    • Special Reports
  • Hot Topics
    • Marketing
    • Sales
    • Deals
    • Regulatory
    • Strategy
    • Technology
    • Meetings
    • R & D
    • Profiles
  • Multimedia
    • Webcasts
    • Podcasts
    • Blog
  • Sponsored Content
    • Country Reports
    • White Papers
    • Pharm Exec 50
    • Industry Audit
    • Woman of the Year
  • Subscribe
    • Pharmaceutical Executive Magazine
    • Pharm Exec Europe Digest
    • Pharm Exec Direct Newsletter
  • Advertise
    • Magazine
    • Media Kit & BPA
    • E-Media Advertising
  • Careers
  • Directories
    • Supplier eDirectory
    • Products & Services
  • Contact Us
    • Editorial
    • Author Guidelines
    • Sales
    • Advertising
    • Lists
    • Reprints

Author Archives: Reid Paul

« Older posts
Newer posts »

Video: Should Pharmacies Be Held to the Same FDA Standards?

By Reid Paul | Published: October 10, 2012
Posted in Corporate Responsibility, FDA, Manufacturing, News, Strategy, compliance | 1 Comment

Video: Think Small, Be Stealthy

By Reid Paul | Published: October 2, 2012
Posted in Biotech, Global, Pharm Exec Magazine, R&D, Sales, Strategy, pricing | Leave a comment

Supreme Court to Consider Sales Rep Overtime

By Reid Paul | Published: April 12, 2012
Posted in Legal, Marketing, People, Podcasts, Sales, Strategy, compliance | Leave a comment

Supreme Court Considers the Affordable Care Act

By Reid Paul | Published: April 9, 2012
Posted in Corporate Responsibility, Legal, Regulatory, Strategy, healthcare | Tagged Democrats, generics, healthcare reform, Medicaid, Medicare, Politics, republican, Republicans, United States Supreme Court | Leave a comment

Witty Touts GSK Pipeline in 4th Quarter Review

By Reid Paul | Published: February 10, 2012
brightcove.createExperiences();
Posted in Emerging Markets, Europe, Global, News, R&D, Strategy | Tagged financial, GlaxoSmithKline, GSK, patent expiries, pipeline, R&D, Research | Leave a comment
« Older posts
Newer posts »